Time to onset of cannabidiol treatment effect and resolution of adverse events in tuberous sclerosis complex: Post hoc analysis of randomized controlled phase 3 trial GWPCARE6-Reference-Cited by-同舟云学术

Time to onset of cannabidiol treatment effect and resolution of adverse events in tuberous sclerosis complex: Post hoc analysis of randomized controlled phase 3 trial GWPCARE6

Published:2022-03-04 Issue:5 Volume:63 Page:1189-1199
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Wu Joyce Y.¹^ORCID,Cock Hannah R.²^ORCID,Devinsky Orrin³^ORCID,Joshi Charuta⁴^ORCID,Miller Ian⁵^ORCID,Roberts Colin M.⁶,Sanchez‐Carpintero Rocio⁷^ORCID,Checketts Daniel⁸,Sahebkar Farhad⁹

Affiliation:

1. Ann and Robert H. Lurie Children's Hospital of Chicago Northwestern University Feinberg School of Medicine Chicago Illinois USA

2. St George's University Hospitals National Health Service Foundation Trust St George's University of London London UK

3. Comprehensive Epilepsy Center NYU Langone Health New York New York USA

4. Children's Hospital Colorado Aurora Colorado USA

5. Nicklaus Children's Hospital Miami Florida USA

6. Oregon Health and Science University Portland Oregon USA

7. University of Navarra Clinic Pamplona Spain

8. GW Research Cambridge UK

9. Greenwich Biosciences Carlsbad California USA

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/epi.17199

Reference35 articles.

1. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference;Northrup H;Pediatr Neurol,2012

2. Tuberous sclerosis

3. The Tuberous Sclerosis Complex

4. Pathogenesis of Tuberous Sclerosis Subependymal Giant Cell Astrocytomas: Biallelic Inactivation ofTSC1orTSC2Leads to mTOR Activation

5. Optimal management of seizures associated with tuberous sclerosis complex: current and emerging options;Wang S;Neuropsychiatr Dis Treat,2014

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus panel recommendations for the optimization of EPIDIOLEX® treatment for seizures associated with Lennox–Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex;Epilepsia Open;2024-07-15

2. A Cost-Utility Analysis of Add-On Cannabidiol Versus Usual Care Alone for the Treatment of Seizures Associated with Tuberous Sclerosis Complex in England and Wales;PharmacoEconomics - Open;2024-03-05

3. Cannabidiol: metabolism and clinical efficacy in epileptic patients;Expert Opinion on Drug Metabolism & Toxicology;2024-03-03

4. Efficacy and safety of six new antiseizure medications for adjunctive treatment of focal epilepsy and epileptic syndrome: A systematic review and network meta-analysis;Epilepsy & Behavior;2024-03

5. Bioengineering of Cannabis Plants from Lab to the Field: Challenges and Opportunities;Concepts and Strategies in Plant Sciences;2024